Recent News
July 2025 • 3 min read
mTatt Takes Home $100K Grand Prize at Startupfest
Recently, mTatt won the grand prize and public choice award at Startupfest, earning a $100,000 grant to accelerate its research and development. This funding will support preclinical animal testing followed by clinical trials in humans.
June 2025 • 3 min read
18 months of IP protection and access to lab space through the Scientific and Innovative Venture Program (SIVP).
This recognition includes financial support, IP protection, and lab space, marking a key milestone in bringing mTatt’s medical innovation to market.
June 2025 • 1 min read
mTatt Spotlighted in InfoBref
Featured recently in InfoBref — a daily newsletter delivering key news to entrepreneurs and investors in just five minutes — mTatt’s innovative approach is gaining well-deserved attention as it aims to transform chronic disease management and reduce hospital visits.
May 2025 • 1 min read
mTatt Welcomes Its First Interns
The team recruited three interns: one in biopharmaceutical sciences to support regulatory work, one in computer science to improve software UX, and one law student to help with IP strategy development.
March 2025 • 2 min read
$2,500 brought home after winning the YEP Pitch Contest
As part of the Young Entrepreneur Program (YEP), a competition designed to support early-stage student-led startups, mTatt’s co-founders pitched the company’s innovation and brought home a $2,500 cash prize to support its development.
January 2025 • 5 min read
mTatt Expands Team with a new co-founder
Catherine Nadeau holds a bachelor’s in biopharmaceutical sciences and is pursuing a master’s in pharmaceutical sciences and a DESS in business. She has received multiple awards for academic excellence, leadership, and research.
September 2025 • 3 min read
Validating Our Market Through V1 Studio Programs
Through the V1 Studio Lab2Market Validation Program, the team was able to clarify its market positioning, validate customer needs, and refine its value proposition with expert support and structured guidance.
June 2024 • 3 min read
mTatt Joins Centech’s Propulsion Program
Centech, one of Canada’s leading deeptech incubators, welcomes mTatt into its high-potential accelerator program.
January 2023 • 5 min read
The Beginning of mTatt
Davide and Samuel founded mTatt after seeing the potential for their microneedle technology to move beyond the lab and bring meaningful change to real-world healthcare.
December 2022 • 1 min read
1st Prize in the Innovinc. RBC – Esquissez 2022 Final
mTatt won its first pitch competition through Innovinc.RBC. The prize includes a $2,500 grant and $375 in legal services to support the launch of the start-up.